Ginkgo Bioworks (DNA) Misses Q3 EPS by 7c

Ginkgo Bioworks (NYSE: DNA) reported Q3 EPS of ($0.16), $0.07 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $55.43 million versus the consensus estimate of $48.08 million.

For earnings history and earnings-related data on Ginkgo Bioworks (DNA) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• SanDisk unveils long-term growth strategy at 2026 Investor Day; Shares surge 12%
• Azitra, Inc. (AZTR) Tops Q2 EPS by 54c